From theheart.org on Medscape

Coverage from the

Society for Cardiovascular Angiography and Intervention (SCAI) 2023

May 18 - 20, 2023; Phoenix, Arizona

May 18 - 20, 2023 Phoenix, Arizona

SCAI 2023 Ticagrelor, DAPT Equal in Preventing Repeat Revascularization After percutaneous coronary intervention, ticagrelor alone or with aspirin are equally effective in preventing repeat revascularization at one year in a post-hoc TWILIGHT analysis.
MDedge News, May 30, 2023
SCAI 2023 Distal Radial Access Doesn't Harm Hand Function at 1 Year A head-to-head comparison of distal vs proximal radial artery access for coronary interventions found no difference in hand function a year later.
MDedge News, May 23, 2023

Conference News

SCAI 2023 Ticagrelor, DAPT Equal in Preventing Repeat Revascularization
MDedge News, May 30, 2023
SCAI 2023 Real-World Data Validate ESC Risk Model in NSTE-ACS
MDedge News, May 25, 2023

SCAI 2023 Distal Radial Access Doesn't Harm Hand Function at 1 Year
MDedge News, May 23, 2023
SCAI 2023 Marijuana Linked to Higher PAD Risk
MDedge News, May 22, 2023

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News From SCAI 2022

SCAI Issues Guidelines for PFO Management, Makes Case for Expansion Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy.
Medscape Medical News, May 20, 2022
No-Implant Interatrial Shunt Remains Patent at a Year A no-implant interatrial shunting procedure showed improved wedge pressure and quality of life for up to 3 months in heart failure recipients.
Medscape Medical News, May 25, 2022
SAFE-PAD Shows Long-Term Safety of Paclitaxel Devices A large study of Medicare claims found no evidence of harmful outcomes associated with drug-eluting stents and balloons for up to 6 years.
Medscape Medical News, May 25, 2022

Previous Coverage

Related Coverage